BRCA1 and breast carcinoma: In another study, 399 women, from 356 non-BRCA1/2 breast cancer families (some had more than one index case because multiple women were affected at the same age), were screened for FANCD2 mutations by DHPLC/sequencing and no pathogenic mutations were identified[18].